Joseph B. El-Khoury, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 30 | 2020 | 1369 | 3.950 |
Why?
|
| Receptors, Scavenger | 10 | 2017 | 123 | 1.550 |
Why?
|
| Amyloid beta-Peptides | 18 | 2019 | 3892 | 1.410 |
Why?
|
| Receptors, Immunologic | 11 | 2019 | 1415 | 1.070 |
Why?
|
| Alzheimer Disease | 16 | 2019 | 8722 | 1.040 |
Why?
|
| Confusion | 2 | 2018 | 278 | 1.020 |
Why?
|
| Phagocytes | 4 | 2013 | 292 | 0.800 |
Why?
|
| Phagocytosis | 15 | 2019 | 1517 | 0.790 |
Why?
|
| Scavenger Receptors, Class A | 6 | 2017 | 52 | 0.690 |
Why?
|
| Macrophages | 18 | 2020 | 5772 | 0.670 |
Why?
|
| Receptors, Lipoprotein | 5 | 2002 | 88 | 0.630 |
Why?
|
| Monocytes | 8 | 2020 | 2591 | 0.620 |
Why?
|
| Roseolovirus Infections | 1 | 2018 | 49 | 0.570 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 97 | 0.560 |
Why?
|
| Meningoencephalitis | 1 | 2018 | 82 | 0.560 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 1086 | 0.560 |
Why?
|
| Complement C1q | 2 | 2016 | 83 | 0.540 |
Why?
|
| Adrenoleukodystrophy | 1 | 2017 | 145 | 0.500 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2013 | 1852 | 0.490 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1885 | 0.470 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1404 | 0.440 |
Why?
|
| Cryptococcus neoformans | 3 | 2009 | 110 | 0.410 |
Why?
|
| Heterozygote | 1 | 2019 | 2796 | 0.410 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3690 | 0.410 |
Why?
|
| Receptors, CCR2 | 3 | 2010 | 215 | 0.410 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 865 | 0.400 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5880 | 0.400 |
Why?
|
| Astrocytes | 3 | 2017 | 1346 | 0.400 |
Why?
|
| Chemokines | 5 | 2010 | 956 | 0.380 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7847 | 0.380 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 61 | 0.370 |
Why?
|
| Brain | 11 | 2020 | 27179 | 0.370 |
Why?
|
| Triterpenes | 1 | 2011 | 77 | 0.370 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 519 | 0.360 |
Why?
|
| Inflammation | 6 | 2018 | 10843 | 0.360 |
Why?
|
| Models, Immunological | 2 | 2017 | 517 | 0.350 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2010 | 656 | 0.340 |
Why?
|
| Glioblastoma | 3 | 2020 | 3458 | 0.340 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 9065 | 0.340 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1600 | 0.330 |
Why?
|
| Mice | 33 | 2020 | 81782 | 0.330 |
Why?
|
| Parasites | 1 | 2012 | 159 | 0.330 |
Why?
|
| Candida albicans | 2 | 2010 | 377 | 0.320 |
Why?
|
| Fungi | 1 | 2012 | 347 | 0.320 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2003 | 340 | 0.320 |
Why?
|
| Animals | 43 | 2020 | 168735 | 0.320 |
Why?
|
| Signal Transduction | 11 | 2019 | 23597 | 0.310 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 186 | 0.300 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 242 | 0.300 |
Why?
|
| Immune System | 1 | 2013 | 799 | 0.280 |
Why?
|
| Immunity, Innate | 4 | 2017 | 3078 | 0.260 |
Why?
|
| Encephalitis | 1 | 2010 | 440 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4394 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2036 | 0.250 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1159 | 0.250 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1037 | 0.240 |
Why?
|
| Glioma | 1 | 2020 | 3491 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 22327 | 0.230 |
Why?
|
| Reactive Oxygen Species | 9 | 2016 | 2141 | 0.230 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 9541 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8603 | 0.220 |
Why?
|
| Plaque, Amyloid | 3 | 2019 | 770 | 0.220 |
Why?
|
| Neurons | 3 | 2019 | 9527 | 0.210 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1463 | 0.210 |
Why?
|
| Oxazolidinones | 1 | 2003 | 99 | 0.210 |
Why?
|
| Vancomycin Resistance | 1 | 2003 | 125 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5752 | 0.210 |
Why?
|
| Apoptosis | 2 | 2016 | 9505 | 0.200 |
Why?
|
| Enterococcus faecium | 1 | 2003 | 101 | 0.200 |
Why?
|
| Cytokines | 6 | 2020 | 7417 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4909 | 0.200 |
Why?
|
| Ligands | 6 | 2017 | 3272 | 0.200 |
Why?
|
| Caenorhabditis elegans | 2 | 2009 | 1480 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11895 | 0.190 |
Why?
|
| Acetamides | 1 | 2003 | 260 | 0.190 |
Why?
|
| Fallopian Tube Diseases | 1 | 2001 | 60 | 0.190 |
Why?
|
| Bacteria | 1 | 2012 | 2210 | 0.180 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1889 | 0.170 |
Why?
|
| Ovarian Diseases | 1 | 2001 | 133 | 0.170 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 4859 | 0.170 |
Why?
|
| Mice, Knockout | 11 | 2019 | 14450 | 0.170 |
Why?
|
| Cell Adhesion | 8 | 2009 | 3089 | 0.170 |
Why?
|
| Cells, Cultured | 12 | 2017 | 18962 | 0.170 |
Why?
|
| Scavenger Receptors, Class B | 5 | 2002 | 84 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2020 | 4130 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2020 | 122 | 0.160 |
Why?
|
| Mucormycosis | 1 | 2020 | 104 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 419 | 0.150 |
Why?
|
| Foscarnet | 1 | 2018 | 36 | 0.150 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1536 | 0.150 |
Why?
|
| Graft vs Host Reaction | 1 | 2018 | 99 | 0.150 |
Why?
|
| Abscess | 1 | 2001 | 605 | 0.150 |
Why?
|
| Moths | 2 | 2010 | 80 | 0.150 |
Why?
|
| Genes, env | 1 | 1997 | 96 | 0.140 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2007 | 39 | 0.140 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 77 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 260 | 0.140 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 63 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2001 | 622 | 0.140 |
Why?
|
| Milk Proteins | 1 | 2017 | 161 | 0.140 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 213 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2019 | 745 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 17060 | 0.130 |
Why?
|
| Disease Progression | 2 | 2015 | 13614 | 0.130 |
Why?
|
| Distal Myopathies | 1 | 2016 | 18 | 0.130 |
Why?
|
| Receptors, Fc | 2 | 1997 | 537 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 985 | 0.130 |
Why?
|
| Facial Paralysis | 1 | 2020 | 346 | 0.130 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 60 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 527 | 0.120 |
Why?
|
| Humans | 41 | 2020 | 765926 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4257 | 0.120 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18292 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2010 | 602 | 0.120 |
Why?
|
| Antibodies | 3 | 2017 | 2415 | 0.110 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1104 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 810 | 0.110 |
Why?
|
| Autopsy | 1 | 2018 | 1011 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2020 | 1888 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3419 | 0.110 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 147 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 169 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1336 | 0.110 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2013 | 16 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 1997 | 1466 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1616 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2003 | 1172 | 0.110 |
Why?
|
| Cholesteatoma | 1 | 2013 | 28 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1835 | 0.110 |
Why?
|
| Endocytosis | 1 | 2017 | 952 | 0.100 |
Why?
|
| Aging | 2 | 2009 | 8725 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 254 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 733 | 0.100 |
Why?
|
| Postmenopause | 1 | 2001 | 2517 | 0.100 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 651 | 0.100 |
Why?
|
| Solubility | 2 | 2013 | 1077 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2020 | 883 | 0.100 |
Why?
|
| Cell Communication | 1 | 2019 | 1660 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1178 | 0.100 |
Why?
|
| Actins | 2 | 2007 | 2057 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1866 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2019 | 3788 | 0.090 |
Why?
|
| Cryptococcosis | 2 | 2009 | 99 | 0.090 |
Why?
|
| Otitis Media | 1 | 2013 | 287 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2011 | 239 | 0.090 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2009 | 29 | 0.090 |
Why?
|
| Collagen | 3 | 1996 | 2616 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 542 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2015 | 545 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 2213 | 0.080 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2009 | 94 | 0.080 |
Why?
|
| Candidiasis | 2 | 2010 | 372 | 0.080 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 112 | 0.080 |
Why?
|
| Cricetulus | 1 | 2011 | 806 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2017 | 1786 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1886 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2015 | 1354 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2013 | 665 | 0.080 |
Why?
|
| Cerebellum | 1 | 2016 | 1519 | 0.080 |
Why?
|
| CHO Cells | 1 | 2011 | 1372 | 0.080 |
Why?
|
| Protein Binding | 4 | 2016 | 9296 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2013 | 10086 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2013 | 683 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2007 | 752 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12973 | 0.070 |
Why?
|
| Chemokine CXCL9 | 1 | 2008 | 137 | 0.070 |
Why?
|
| Cricetinae | 1 | 2011 | 2412 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2013 | 2075 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1999 | 218 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 5765 | 0.070 |
Why?
|
| Receptors, CXCR3 | 1 | 2008 | 240 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1432 | 0.070 |
Why?
|
| Gene Expression | 2 | 2017 | 7581 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 347 | 0.070 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 310 | 0.070 |
Why?
|
| Malaria, Cerebral | 1 | 2008 | 136 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1643 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 4277 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2194 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3940 | 0.070 |
Why?
|
| Plasmids | 1 | 2011 | 2267 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 587 | 0.060 |
Why?
|
| Leukotriene B4 | 2 | 1999 | 281 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2009 | 552 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2018 | 3053 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2270 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7073 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 8060 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2007 | 11030 | 0.060 |
Why?
|
| Fibrin | 2 | 1999 | 514 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2019 | 699 | 0.060 |
Why?
|
| Proteomics | 1 | 2017 | 3906 | 0.050 |
Why?
|
| Lyme Disease | 1 | 2009 | 627 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2015 | 2061 | 0.050 |
Why?
|
| Chemotaxis | 2 | 2003 | 596 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2157 | 0.050 |
Why?
|
| Glucose | 1 | 1994 | 4335 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6202 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 887 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2009 | 643 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 7043 | 0.050 |
Why?
|
| Peroxides | 1 | 2002 | 76 | 0.050 |
Why?
|
| Biological Assay | 1 | 2004 | 626 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3562 | 0.050 |
Why?
|
| Male | 8 | 2020 | 363815 | 0.050 |
Why?
|
| Tyrosine | 3 | 2007 | 1427 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2411 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10426 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2003 | 4342 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 858 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3212 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2004 | 900 | 0.040 |
Why?
|
| Neutrophils | 3 | 1999 | 3769 | 0.040 |
Why?
|
| HIV-1 | 1 | 1997 | 6945 | 0.040 |
Why?
|
| Dysarthria | 1 | 2020 | 57 | 0.040 |
Why?
|
| Opsonin Proteins | 1 | 2000 | 138 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3801 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22228 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2000 | 70 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1242 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1055 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2020 | 174 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 6101 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 161 | 0.040 |
Why?
|
| Empathy | 1 | 2003 | 474 | 0.040 |
Why?
|
| Cell Line | 3 | 2009 | 15540 | 0.040 |
Why?
|
| Amyloid | 1 | 2003 | 848 | 0.040 |
Why?
|
| Cell Movement | 3 | 2008 | 5190 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 331 | 0.040 |
Why?
|
| Paxillin | 1 | 2007 | 86 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2007 | 87 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 8279 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18382 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1997 | 283 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 705 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 434 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 740 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 159 | 0.030 |
Why?
|
| Fetus | 1 | 2002 | 1878 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2009 | 5019 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 159 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 265 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 582 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 340 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13398 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1994 | 149 | 0.030 |
Why?
|
| Earache | 1 | 2013 | 14 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1994 | 348 | 0.030 |
Why?
|
| Rats | 2 | 2002 | 23708 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1994 | 564 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 239 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 223016 | 0.030 |
Why?
|
| Female | 8 | 2020 | 396141 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 13082 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17596 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 146 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1206 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18074 | 0.020 |
Why?
|
| Hearing Loss, Conductive | 1 | 2013 | 159 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 691 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 473 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 30192 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 478 | 0.020 |
Why?
|
| Zymosan | 1 | 1991 | 128 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2015 | 567 | 0.020 |
Why?
|
| Protein Folding | 1 | 2015 | 868 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 17531 | 0.020 |
Why?
|
| United States | 2 | 2017 | 72909 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6209 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1392 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 582 | 0.020 |
Why?
|
| Immunization | 1 | 2015 | 1218 | 0.020 |
Why?
|
| src-Family Kinases | 2 | 2003 | 538 | 0.020 |
Why?
|
| Slovenia | 1 | 2009 | 22 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1489 | 0.020 |
Why?
|
| Hyphae | 1 | 2010 | 52 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 74850 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 998 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4563 | 0.020 |
Why?
|
| Tuftsin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 825 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3225 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5126 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 695 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3801 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1239 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 871 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 608 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 257 | 0.020 |
Why?
|
| Plasmodium berghei | 1 | 2008 | 161 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2020 | 5987 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2114 | 0.020 |
Why?
|
| Hemocytes | 1 | 2005 | 48 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Headache | 1 | 2013 | 1261 | 0.010 |
Why?
|
| Peptides | 1 | 1996 | 4331 | 0.010 |
Why?
|
| Foam Cells | 1 | 2003 | 67 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20690 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 114 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 223088 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2341 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12822 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2294 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1991 | 2394 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 812 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 665 | 0.010 |
Why?
|
| Virulence | 1 | 2005 | 1289 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2248 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1998 | 2219 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12768 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 42510 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8492 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 769 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1590 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9600 | 0.010 |
Why?
|
| Scopoletin | 1 | 1998 | 2 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6503 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8037 | 0.010 |
Why?
|
| Catalase | 1 | 1998 | 214 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 833 | 0.010 |
Why?
|
| Calcium | 1 | 1991 | 5769 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 822 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9351 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 171163 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1997 | 107 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15878 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 65194 | 0.010 |
Why?
|
| Acetylation | 1 | 1998 | 1054 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 3945 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5738 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1140 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2444 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 1833 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 1994 | 10 | 0.010 |
Why?
|
| Child | 1 | 2003 | 80568 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 88811 | 0.010 |
Why?
|
| Models, Biological | 2 | 2002 | 9443 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4641 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3419 | 0.010 |
Why?
|
| Benzoxazoles | 1 | 1994 | 93 | 0.010 |
Why?
|
| Laminin | 1 | 1995 | 404 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1994 | 350 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1998 | 1017 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1995 | 793 | 0.010 |
Why?
|
| Acridine Orange | 1 | 1991 | 28 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1991 | 37 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1991 | 91 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6891 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 59496 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 135 | 0.010 |
Why?
|
| Magnesium | 1 | 1994 | 815 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1998 | 9239 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4520 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 751 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 2001 | 0.000 |
Why?
|
| Time Factors | 2 | 2003 | 40097 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1927 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 59857 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36547 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1991 | 2627 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4555 | 0.000 |
Why?
|